US and China clash over fentanyl and tariffs at global drugs meeting

At a U.N. drugs meeting, the U.S. accused China of failing to stop sales of precursor chemicals for fentanyl, and China denied the claim, calling the U.S. irresponsible. The diplomatic spat raises bilateral tensions and could increase pressure for tighter export controls or regulatory measures on controlled chemicals, though there are no immediate market-moving actions reported.

Analysis

At a U.N. drugs meeting, the U.S. accused China of failing to stop sales of precursor chemicals for fentanyl, and China denied the claim, calling the U.S. irresponsible. The diplomatic spat raises bilateral tensions and could increase pressure for tighter export controls or regulatory measures on controlled chemicals, though there are no immediate market-moving actions reported.